SpectraCure (Sweden) Probability of Future Stock Price Finishing Over 1.85
| SPEC Stock | SEK 1.65 0.07 4.43% |
SpectraCure |
SpectraCure Target Price Odds to finish over 1.85
The tendency of SpectraCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 1.85 or more in 90 days |
| 1.65 | 90 days | 1.85 | about 66.73 |
Based on a normal probability distribution, the odds of SpectraCure to move over kr 1.85 or more in 90 days from now is about 66.73 (This SpectraCure AB probability density function shows the probability of SpectraCure Stock to fall within a particular range of prices over 90 days) . Probability of SpectraCure AB price to stay between its current price of kr 1.65 and kr 1.85 at the end of the 90-day period is about 16.74 .
Assuming the 90 days trading horizon SpectraCure AB has a beta of -0.34. This usually implies as returns on the benchmark increase, returns on holding SpectraCure are expected to decrease at a much lower rate. During a bear market, however, SpectraCure AB is likely to outperform the market. Additionally SpectraCure AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. SpectraCure Price Density |
| Price |
Predictive Modules for SpectraCure
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SpectraCure AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.SpectraCure Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. SpectraCure is not an exception. The market had few large corrections towards the SpectraCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SpectraCure AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SpectraCure within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | -0.34 | |
σ | Overall volatility | 0.37 | |
Ir | Information ratio | -0.06 |
SpectraCure Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SpectraCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SpectraCure AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| SpectraCure AB generated a negative expected return over the last 90 days | |
| SpectraCure AB has high historical volatility and very poor performance | |
| SpectraCure AB may become a speculative penny stock | |
| The company reported the revenue of 5.75 M. Net Loss for the year was (23.34 M) with profit before overhead, payroll, taxes, and interest of 2.99 M. | |
| SpectraCure AB has accumulated about 129.69 M in cash with (18.6 M) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
SpectraCure Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of SpectraCure Stock often depends not only on the future outlook of the current and potential SpectraCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SpectraCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 129.7 M |
SpectraCure Technical Analysis
SpectraCure's future price can be derived by breaking down and analyzing its technical indicators over time. SpectraCure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of SpectraCure AB. In general, you should focus on analyzing SpectraCure Stock price patterns and their correlations with different microeconomic environments and drivers.
SpectraCure Predictive Forecast Models
SpectraCure's time-series forecasting models is one of many SpectraCure's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary SpectraCure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about SpectraCure AB
Checking the ongoing alerts about SpectraCure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for SpectraCure AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| SpectraCure AB generated a negative expected return over the last 90 days | |
| SpectraCure AB has high historical volatility and very poor performance | |
| SpectraCure AB may become a speculative penny stock | |
| The company reported the revenue of 5.75 M. Net Loss for the year was (23.34 M) with profit before overhead, payroll, taxes, and interest of 2.99 M. | |
| SpectraCure AB has accumulated about 129.69 M in cash with (18.6 M) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Additional Tools for SpectraCure Stock Analysis
When running SpectraCure's price analysis, check to measure SpectraCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectraCure is operating at the current time. Most of SpectraCure's value examination focuses on studying past and present price action to predict the probability of SpectraCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectraCure's price. Additionally, you may evaluate how the addition of SpectraCure to your portfolios can decrease your overall portfolio volatility.